Publications

BibTex format

@article{Obón-Santacana:2020:10.1002/ijc.32415,
author = {Obón-Santacana, M and Luján-Barroso, L and Freisling, H and Naudin, S and Boutron-Ruault, M-C and Mancini, FR and Rebours, V and Kühn, T and Katzke, V and Boeing, H and Tjønneland, A and Olsen, A and Overvad, K and Lasheras, C and Rodríguez-Barranco, M and Amiano, P and Santiuste, C and Ardanaz, E and Khaw, K-T and Wareham, NJ and Schmidt, JA and Aune, D and Trichopoulou, A and Thriskos, P and Peppa, E and Masala, G and Grioni, S and Tumino, R and Panico, S and Bueno-de-Mesquita, B and Sciannameo, V and Vermeulen, R and Sonestedt, E and Sund, M and Weiderpass, E and Skeie, G and González, CA and Riboli, E and Duell, EJ},
doi = {10.1002/ijc.32415},
journal = {International Journal of Cancer},
pages = {76--84},
title = {Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition},
url = {http://dx.doi.org/10.1002/ijc.32415},
volume = {146},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Four epidemiologic studies have assessed the association between nut intake and pancreatic cancer risk with contradictory results. The present study aims to investigate the relation between nut intake (including seeds) and pancreatic ductal adenocarcinoma (PDAC) risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Cox proportional hazards models were used to estimate hazards ratio (HR) and 95% confidence intervals (95% CI) for nut intake and PDAC risk. Information on intake of nuts was obtained from the EPIC country-specific dietary questionnaires. After a mean follow-up of 14 years, 476,160 participants were eligible for the present study and included 1,283 PDAC cases. No association was observed between consumption of nuts and PDAC risk (highest intake vs nonconsumers: HR, 0.89; 95% CI, 0.72-1.10; p-trend = 0.70). Furthermore, no evidence for effect-measure modification was observed when different subgroups were analyzed. Overall, in EPIC, the highest intake of nuts was not statistically significantly associated with PDAC risk.
AU  - Obón-Santacana,M
AU  - Luján-Barroso,L
AU  - Freisling,H
AU  - Naudin,S
AU  - Boutron-Ruault,M-C
AU  - Mancini,FR
AU  - Rebours,V
AU  - Kühn,T
AU  - Katzke,V
AU  - Boeing,H
AU  - Tjønneland,A
AU  - Olsen,A
AU  - Overvad,K
AU  - Lasheras,C
AU  - Rodríguez-Barranco,M
AU  - Amiano,P
AU  - Santiuste,C
AU  - Ardanaz,E
AU  - Khaw,K-T
AU  - Wareham,NJ
AU  - Schmidt,JA
AU  - Aune,D
AU  - Trichopoulou,A
AU  - Thriskos,P
AU  - Peppa,E
AU  - Masala,G
AU  - Grioni,S
AU  - Tumino,R
AU  - Panico,S
AU  - Bueno-de-Mesquita,B
AU  - Sciannameo,V
AU  - Vermeulen,R
AU  - Sonestedt,E
AU  - Sund,M
AU  - Weiderpass,E
AU  - Skeie,G
AU  - González,CA
AU  - Riboli,E
AU  - Duell,EJ
DO  - 10.1002/ijc.32415
EP  - 84
PY  - 2020///
SN  - 0020-7136
SP  - 76
TI  - Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition
T2  - International Journal of Cancer
UR  - http://dx.doi.org/10.1002/ijc.32415
UR  - https://www.ncbi.nlm.nih.gov/pubmed/31107546
UR  - http://hdl.handle.net/10044/1/70996
VL  - 146
ER  -

Download

ProfessorElioRiboli

Contact

Assistant

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)